Innovation

Section Score

Section Grade

Global Health Research

What percentage of the university’s total funding received is dedicated to global health research, training and collaborations?

Neglected Disease Research

What percentage of the university's total medical research funding is devoted to projects focused on neglected diseases?

Publications on Global Health

What percentage of the university's total medical PubMed publications are focused on global health?

Publications on Neglected Health Needs

What total percentage of the university’s total medical PubMed publications are focused on neglected diseases; diseases with recorded outbreaks, epidemics, or pandemics; and/or neglected aspects of HIV, TB, malaria, or AMR in low and lower-middle income countries?

Dedicated Research Centers

Does the university have a research center or institute dedicated specifically to neglected diseases and or HIV/AIDS, TB, Malaria, or AMR?

details

Access

Section Score

Section Grade

Licensing Commitments

Does the university license its medical discoveries in ways that promote global health equity?

Has the university officially and publicly committed to licensing its medical discoveries in ways that promote access and affordability in lower and middle income countries?

Does the website of the university's technology transfer office (TTO) make an effort to disclose, explain and promote access licensing commitments and practices?

Open Access Publications

What percentage of the university's total medical sciences publication output is published in open-access publications?

Non-Exclusive Licensing

In the past year, what percentage of the university's health technology licenses was non-exclusive?

Patents

In the past year, for what percentage of all health technologies did the university seek patents in for in...

Upper-middle-income countries?

Low- and lower-middle-income countries ?

Access Provisions in Exclusive Licensing

In the past year, what percentage of the university’s exclusive licenses of health technologies from the TTO included provisions to promote access to those technologies in...

Low- and lower-middle-income countries (as defined by the World Bank)?

Upper-middle-income countries (as defined by the World Bank)?

High-income countries (as defined by the World Bank)?

Best Practice Sharing

Has the university shared its best practices for promoting access to medicines through licensing? Check all that apply:
❏ Contributed sample clauses to the AUTM Global Health Toolkit
❏ Published an article on access licensing practices
❏ Formally presented on access licensing practices at an academic or professional event
❏ Informally shared or discussed access licensing practices with administrators at other universities
❏ Other: Please explain

Contributions to International IP Pools

Has the university recently submitted a medical patent(s) to the Medicines Patents Pool (MPP) or World Intellectual Property Organziation's (WIPO) Re:Search?

details

Empowerment

Section Score

Section Grade

Global Health Programs

Does the university offer its students access to global health engagement and/or education?

As indicated by the existence of a university center/institute, department, and/or non-degree program in global health.

As indicated by the existence of a university graduate degree, major/concentration, focus/specialization, certificate, or undergraduate degree in global health.

Education Opportunities on Global Access Principles

Does the university’s (a) medical school/residency program, (b) public health school, and/or (c) law school offer graduate courses that address the policy and legal context of biomedical R&D, and more specifically the impact of intellectual property policies, on research priorities and global access to medical innovations?

Education Opportunities on Neglected Diseases

Does the university’s (a) undergraduate program, (b) medical school/residency program, (c) public health school, and/or (d) law school offer graduate courses that address the prevalence of and/or lack of research on neglected diseases, including neglected aspects of HIV, TB, AMR, and/or malaria?

Conferences and Events

Has the university hosted a major conference, symposium or campus-wide event from 2014-2016 on the following topics:

(A) The policy and legal context of biomedical R&D, specifically the impact of intellectual property rights on research priorities and global access to medical innovations

(B) Neglected diseases, including neglected aspects of HIV, TB, AMR, malaria, and/or Zika and health needs of low- and middle-income countries

Educational Opportunities Abroad

Does the university offer any of its students accessible opportunities to study, work, or complete research abroad in global health?

details

Transparency

Section Score

Section Grade

Disclosure of Clinical Trial Funding

Does the university disclose the amount of public funding received for clinical trials? Check all that apply:
❏ Discloses funding to public registries
❏ Disclosures sources of private funding
❏ Disclosure of all public and philanthropic funding
❏ Maintains a public database of funding sources for individual grants
❏ Responds to public records requests disclosing information on corporate sponsored research
❏ Reports funds that are received through a foundation housed in the academic institution and/or headed by a principal investigator at the university

Publication of Clinical Trial Data

What percent of all clinical trial data was published between...?

2006-2015 - Based on online sources

2006-2015 - Based on university self-reported data

2014-2015 - Based on online sources

2014-2015 - Based on university self-reported data

Policies Mandating the Publication of Clinical Trial Results

Does your university have policies that mandate that all university researchers publish all results of all clinical trials?

Acknowledgements of the Importance of Clinical Trial Transparency

Has the university publicly acknowledged the need to be transparent in clinical trial results by:
❏ Signing/endorsing the World Health Organization's Joint statement on public disclosure of clinical trial results
❏ Endorsing the Institute of Medicine’s Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk⁠ Report
❏ Endorsing UAEM's global campaign on University Norms on Transparency
❏ Publishing an statement in support of clinical trial data transparency and the need to publish all clinical trial results on their Univerisity website

Prospective Registration of Clinical Trials

Do you recommend or require your researchers to prospectively register all clinical trials with an appropriate registry before any subject is enrolled?

(a) If no, do you ensure all trials are registered before data is submitted to an academic journal for publication?

(b) If yes, in addition to trials being prospectively registered, do you require protocols and planned outcomes for your university trials public before the trial begins?
↳ If no, do you provide credit to investigators who choose to share protocols for their planned, ongoing, or completed trials?

Privately Commissioned Research

Do you engage in commissioned research from private companies?
↳ If yes, do these companies have the ability to insert clauses affecting or prevent data publication?

Sufficiency of Public Data

For questions relying on public data, was sufficient information available online?

For Access section questions

For Innovation section questions

For Empowerment section questions

For Transparency section questions

Response Discrepancy

For questions which used both universities' responses to the standardized survey and information collected using publicly available data, how much discrepancy existed between these two data sources?

details

COVID-19

Section Score

Section Grade

COVID-19 Biomedical Technology Commitments

Has the university publicly committed to any open science frameworks that increase access to COVID-19 related health technologies? Options include:
❏ AUTM's COVID-19 Licensing Guidelines
❏ The COVID-19 Technology Access Framework
❏ The World Health Organization’s COVID-19 Technology Access Pool
❏ The Open Covid Pledge
❏ Other: Please elaborate.

Comparison Tool

Innovation

Section Score

Section Grade

Global Health Research

What percentage of the university’s total funding received is dedicated to global health research, training and collaborations?

Neglected Disease Research

What percentage of the university's total medical research funding is devoted to projects focused on neglected diseases?

Publications on Global Health

What percentage of the university's total medical PubMed publications are focused on global health?

Publications on Neglected Health Needs

What total percentage of the university’s total medical PubMed publications are focused on neglected diseases; diseases with recorded outbreaks, epidemics, or pandemics; and/or neglected aspects of HIV, TB, malaria, or AMR in low and lower-middle income countries?

Dedicated Research Centers

Does the university have a research center or institute dedicated specifically to neglected diseases and or HIV/AIDS, TB, Malaria, or AMR?

Access

Section Score

Section Grade

Licensing Commitments

Does the university license its medical discoveries in ways that promote global health equity?

Has the university officially and publicly committed to licensing its medical discoveries in ways that promote access and affordability in lower and middle income countries?

Does the website of the university's technology transfer office (TTO) make an effort to disclose, explain and promote access licensing commitments and practices?

Open Access Publications

What percentage of the university's total medical sciences publication output is published in open-access publications?

Non-Exclusive Licensing

In the past year, what percentage of the university's health technology licenses was non-exclusive?

Patents

In the past year, for what percentage of all health technologies did the university seek patents in for in...

Upper-middle-income countries?

Low- and lower-middle-income countries ?

Access Provisions in Exclusive Licensing

In the past year, what percentage of the university’s exclusive licenses of health technologies from the TTO included provisions to promote access to those technologies in...

Low- and lower-middle-income countries (as defined by the World Bank)?

Upper-middle-income countries (as defined by the World Bank)?

High-income countries (as defined by the World Bank)?

Best Practice Sharing

Contributions to International IP Pools

Has the university recently submitted a medical patent(s) to the Medicines Patents Pool (MPP) or World Intellectual Property Organziation's (WIPO) Re:Search?

Empowerment

Section Score

Section Grade

Global Health Programs

Does the university offer its students access to global health engagement and/or education?

As indicated by the existence of a university center/institute, department, and/or non-degree program in global health.

As indicated by the existence of a university graduate degree, major/concentration, focus/specialization, certificate, or undergraduate degree in global health.

Education Opportunities on Global Access Principles

Education Opportunities on Neglected Diseases

Does the university’s (a) undergraduate program, (b) medical school/residency program, (c) public health school, and/or (d) law school offer graduate courses that address the prevalence of and/or lack of research on neglected diseases, including neglected aspects of HIV, TB, AMR, and/or malaria?

Conferences and Events

Educational Opportunities Abroad

Does the university offer any of its students accessible opportunities to study, work, or complete research abroad in global health?

Transparency

Section Score

Section Grade

Disclosure of Clinical Trial Funding

Publication of Clinical Trial Data

What percent of all clinical trial data was published between...?

2006-2015 - Based on online sources

2006-2015 - Based on university self-reported data

2014-2015 - Based on online sources

2014-2015 - Based on university self-reported data

Policies Mandating the Publication of Clinical Trial Results

Does your university have policies that mandate that all university researchers publish all results of all clinical trials?

Acknowledgements of the Importance of Clinical Trial Transparency

Prospective Registration of Clinical Trials

Privately Commissioned Research

Do you engage in commissioned research from private companies? ↳ If yes, do these companies have the ability to insert clauses affecting or prevent data publication?

Sufficiency of Public Data

For questions relying on public data, was sufficient information available online?

For Access section questions

For Innovation section questions

For Empowerment section questions

For Transparency section questions

Response Discrepancy

For questions which used both universities' responses to the standardized survey and information collected using publicly available data, how much discrepancy existed between these two data sources?

COVID-19

Section Score

Section Grade

COVID-19 Biomedical Technology Commitments

Total

Overall Score (weighted)

Do you engage in commissioned research from private companies?
↳ If yes, do these companies have the ability to insert clauses affecting or prevent data publication?